Higher post‐prandial glucose excursions in youth with type 1 diabetes and celiac disease: Time to change the bolus?
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Marco Marigliano, Enza Mozzillo, Roberta Romanelli, Stefano Passanisi, Giuseppina Salzano, Francesca Di Candia, Claudio Maffeis, Roberto Franceschi |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Time in tight range in automated insulin delivery system users: Real‐world data from children and adolescents with type 1 diabetes
by: Claudia Piona, et al.
Published: (2024)
by: Claudia Piona, et al.
Published: (2024)
Omnipod 5 in children and adolescents with type 1 diabetes: Improved outcomes with fewer boluses
by: Davide Tinti, et al.
Published: (2025)
by: Davide Tinti, et al.
Published: (2025)
Glucose sensor with predictive alarm for hypoglycaemia: Improved glycaemic control in adolescents with type 1 diabetes
by: Marco Marigliano, et al.
Published: (2024)
by: Marco Marigliano, et al.
Published: (2024)
Reduced prandial insulin secretion contributes to prandial hyperglycaemia in non‐diabetic individuals with spinal cord injury
by: Michelle Trbovich, et al.
Published: (2025)
by: Michelle Trbovich, et al.
Published: (2025)
Optimising the CamAPS FX automated insulin delivery system for exercise and complex meals in adolescents with type 1 diabetes: A prospective interventional study in a camp setting
by: Andrea E. Scaramuzza, et al.
Published: (2025)
by: Andrea E. Scaramuzza, et al.
Published: (2025)
Glycaemic control metrics and metabolic dysfunction–associated steatotic liver disease in children and adolescents with type 1 diabetes
by: Claudio Maffeis, et al.
Published: (2024)
by: Claudio Maffeis, et al.
Published: (2024)
Importance of targeting post‐prandial hyperglycaemia to achieve HbA1c goals in insulin glargine‐treated subphenotypes of type 2 diabetes
by: Wolfgang Landgraf, et al.
Published: (2025)
by: Wolfgang Landgraf, et al.
Published: (2025)
Differential effect of endogenous glucagon‐like peptide‐1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery
by: Henri Honka, et al.
Published: (2024)
by: Henri Honka, et al.
Published: (2024)
Follow‐up and monitoring programme in children identified in early‐stage type 1 diabetes during screening in the general population of Italy
by: Valentino Cherubini, et al.
Published: (2024)
by: Valentino Cherubini, et al.
Published: (2024)
Accuracy of the professional flash glucose monitoring system FreeStyle Libre Pro in hospitalized individuals with type 2 diabetes mellitus receiving standardized basal‐bolus insulin therapy
by: Felix Aberer, et al.
Published: (2024)
by: Felix Aberer, et al.
Published: (2024)
Development and validation of a novel method for evaluation of multiple islet autoantibodies in dried blood spot using dissociation‐enhanced lanthanide fluorescent immunoassays technology, specific and suitable for paediatric screening programmes
by: Beatrice Dufrusine, et al.
Published: (2024)
by: Beatrice Dufrusine, et al.
Published: (2024)
Glucose‐dependent insulinotropic polypeptide reduces postprandial glucose excursions but does not protect from hypoglycaemia in persons with type 1 diabetes—A randomised placebo‐controlled study
by: Bjørn Hoe, et al.
Published: (2025)
by: Bjørn Hoe, et al.
Published: (2025)
Efficacy of telemedicine on glycaemic control in nursing home residents with type 2 diabetes on basal‐bolus insulin therapy: A randomised controlled trial
by: Ilaria Dicembrini, et al.
Published: (2026)
by: Ilaria Dicembrini, et al.
Published: (2026)
Contributions of intermittently scanned continuous glucose monitoring frequency and bolus insulin dosing on time in range: Analysis of data from CGM and connected insulin pens
by: Pratik Choudhary, et al.
Published: (2025)
by: Pratik Choudhary, et al.
Published: (2025)
Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring
by: Howard Wolpert, et al.
Published: (2025)
by: Howard Wolpert, et al.
Published: (2025)
The effect of bolus advisors on glycaemic parameters in adults with diabetes on intensive insulin therapy: A systematic review with meta‐analysis
by: Elisabeth J. den Brok, et al.
Published: (2024)
by: Elisabeth J. den Brok, et al.
Published: (2024)
Change in glycated haemoglobin in adults with type 2 diabetes on basal‐bolus insulin regimens following commencement of Freestyle Libre use
by: Anna R. Dover, et al.
Published: (2024)
by: Anna R. Dover, et al.
Published: (2024)
Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real‐world analysis
by: Satish K. Garg, et al.
Published: (2024)
by: Satish K. Garg, et al.
Published: (2024)
Cost‐utility analysis of once‐weekly insulin icodec and once‐daily insulin glargine in patients with type 2 diabetes receiving basal‐bolus insulin therapy in China
by: Nan Dai, et al.
Published: (2024)
by: Nan Dai, et al.
Published: (2024)
Long‐term blood glucose control via glucose‐activated transcriptional regulation of insulin analogue in type 1 diabetes mice
by: Wanling Lu, et al.
Published: (2025)
by: Wanling Lu, et al.
Published: (2025)
Unveiling glycaemic variability patterns linked to the triglyceride‐glucose index in type 2 diabetes: Insights from continuous glucose monitoring
by: Yunxiao Wu, et al.
Published: (2026)
by: Yunxiao Wu, et al.
Published: (2026)
Comparative safety of glucose‐lowering medications on depression in adults with type 2 diabetes
by: Stephanie A. Hooker, et al.
Published: (2026)
by: Stephanie A. Hooker, et al.
Published: (2026)
The association between inflammation and glucose levels in hospitalised patients with type 2 diabetes
by: Mikkel T. Olsen, et al.
Published: (2025)
by: Mikkel T. Olsen, et al.
Published: (2025)
Pre‐dinner walks may be superior to post‐dinner walks for glucose time in range in adults with type 1 diabetes on hybrid closed‐loop insulin delivery systems
by: Lauren V. Turner, et al.
Published: (2024)
by: Lauren V. Turner, et al.
Published: (2024)
Are We Ready With Prevention for Type 1 Diabetes?
by: Evelina Maines, et al.
Published: (2025)
by: Evelina Maines, et al.
Published: (2025)
The role of real‐time continuous glucose monitoring in diabetes management and how it should link to integrated personalized diabetes management
by: Monika Reddy, et al.
Published: (2024)
by: Monika Reddy, et al.
Published: (2024)
Cost‐effectiveness of sodium‐glucose cotransporter‐2 inhibitors in the treatment of diabetic nephropathy in Japan
by: Keiko Maruyama‐Sakurai, et al.
Published: (2024)
by: Keiko Maruyama‐Sakurai, et al.
Published: (2024)
Modelling and assessment of glucose‐lactate kinetics in youth with overweight, obesity and metabolic dysfunction‐associated steatotic liver disease: A pilot study
by: Jacopo Bonet, et al.
Published: (2024)
by: Jacopo Bonet, et al.
Published: (2024)
Efficacy of 1‐hour postload plasma glucose as a suitable measurement in predicting type 2 diabetes and diabetes‐related complications: A post hoc analysis of the 30‐year follow‐up of the Da Qing IGT and Diabetes Study
by: Minying Peng, et al.
Published: (2024)
by: Minying Peng, et al.
Published: (2024)
Effectiveness and safety of once‐weekly subcutaneous semaglutide versus other glucose‐lowering agents in real‐world patients with type 2 diabetes: A retrospective, observational post‐marketing study
by: Chenyang Shi, et al.
Published: (2024)
by: Chenyang Shi, et al.
Published: (2024)
Long‐term adherence to glucose‐lowering medications in adults with diabetes: A data linkage study
by: Crystal M. Y. Lee, et al.
Published: (2025)
by: Crystal M. Y. Lee, et al.
Published: (2025)
Metformin slows intestinal glucose absorption in type 2 diabetes, irrespective of the timing of its administration
by: Malcolm J. Borg, et al.
Published: (2025)
by: Malcolm J. Borg, et al.
Published: (2025)
Continuous glucose monitoring and all‐cause mortality in insulin‐using population with diabetes and cognitive impairment
by: Pareeta Kotecha, et al.
Published: (2024)
by: Pareeta Kotecha, et al.
Published: (2024)
Heterogeneity of continuous glucose monitoring features and their clinical associations in a type 2 diabetes population
by: Elizabeth Healey, et al.
Published: (2025)
by: Elizabeth Healey, et al.
Published: (2025)
Clinically relevant stratification of patients with type 2 diabetes by using continuous glucose monitoring data
by: Xiaopeng Shao, et al.
Published: (2024)
by: Xiaopeng Shao, et al.
Published: (2024)
Could continuous subcutaneous glucose sensors ( CGMS ) be repurposed to diagnose diabetes in equivocal or challenging cases?
by: Martin B. Whyte, et al.
Published: (2025)
by: Martin B. Whyte, et al.
Published: (2025)
Workplace‐based continuous glucose monitoring with structured education for pre‐diabetes and type 2 diabetes: A prospective community cohort study
by: Ji‐Hee Ko, et al.
Published: (2025)
by: Ji‐Hee Ko, et al.
Published: (2025)
Slowing the progression of diabetic and non‐diabetic kidney disease: A summary of the current evidence base for sodium‐glucose co‐transporter‐2 inhibitors
by: Viktor Rotbain Curovic, et al.
Published: (2024)
by: Viktor Rotbain Curovic, et al.
Published: (2024)
Risk of recurrent diabetic ketoacidosis following initiation of sodium‐glucose co‐transporter 2 inhibitors in patients with an insulin‐deficient diabetes and prior diabetic ketoacidosis: An observational cohort study
by: Anat Tsur, et al.
Published: (2026)
by: Anat Tsur, et al.
Published: (2026)
Cost‐effectiveness analysis of Dexcom ONE + real‐time continuous glucose monitoring versus self‐monitoring of blood glucose in people with type 2 diabetes in Aotearoa New Zealand
by: Ryan G. Paul, et al.
Published: (2026)
by: Ryan G. Paul, et al.
Published: (2026)
Similar Items
-
Time in tight range in automated insulin delivery system users: Real‐world data from children and adolescents with type 1 diabetes
by: Claudia Piona, et al.
Published: (2024) -
Omnipod 5 in children and adolescents with type 1 diabetes: Improved outcomes with fewer boluses
by: Davide Tinti, et al.
Published: (2025) -
Glucose sensor with predictive alarm for hypoglycaemia: Improved glycaemic control in adolescents with type 1 diabetes
by: Marco Marigliano, et al.
Published: (2024) -
Reduced prandial insulin secretion contributes to prandial hyperglycaemia in non‐diabetic individuals with spinal cord injury
by: Michelle Trbovich, et al.
Published: (2025) -
Optimising the CamAPS FX automated insulin delivery system for exercise and complex meals in adolescents with type 1 diabetes: A prospective interventional study in a camp setting
by: Andrea E. Scaramuzza, et al.
Published: (2025)